Dayong Li, Ph.D., joined Marinus as Vice President of Biometrics, responsible for overseeing and ensuring effective operations in biostatistics, data management, and statistical programming.

Dr. Li brings 25 years of experience in clinical drug development and clinical statistics.
Prior to Marinus, he led biometrics teams at pharmaceutical and biotech companies such as Forest Laboratories (Now Abbvie) where he co-authored clinical study reports, manuscripts, developed study protocols and statistical analysis plans, and participated in planning activities as a lead statistician for projects.
As Director of Biostatistics at AstraZeneca, Dr. Li provided strategic input for product development, marketing, and life cycle management. In addition, he brought modern statistical methodologies to the company, applying them to design and analysis of clinical studies.

Dr. Li has been a major contributor to several FDA approved drug products giving him in depth knowledge and experience in 10+ NDA/sNDA submissions with a high approval rate. Dr. Li earned his Ph.D. in statistics from The University of Maryland Baltimore County and his B.S. in Mathematics from Henan Normal University, China.